CBX8 and neoplasm: Our study found that in LIHC patients, CBX8 expression was obviously higher in stages II-III than in stage I. In KIRC patients, CBX8 expression was obviously higher in stage IV than in stage I, suggesting that CBX8 can be a supervision index for distant tumor metastases in LIHC and KIRC.